RHYTHM PHARMACEUTICALS TO ANNOUNCE PRELIMINARY DATA FROM EXPLORATORY PHASE 2 TRIAL EVALUATING SETMELANOTIDE IN PRADER-WILLI SYNDROME

Reuters · 1d ago

Please log in to view news